Att 2_60 day FRN

12360

Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices

level and any faculty changes. Sponsors
who elect to have their approval
renewed for an additional 5 year period
submit a renewal application and
supporting documentation for review by
NIOSH staff to ensure the course
curriculum meets all current standard
requirements.
Approved courses that elect to offer
NIOSH-Approved Spirometry Refresher
Courses must submit a separate
application and supporting documents
for review by NIOSH staff. Institutions

and organizations throughout the
country voluntarily submit applications
and materials to become course
sponsors and carry out training.
Submissions are required for NIOSH to
evaluate a course and determine
whether it meets the criteria in the
Standard and whether technicians will
be adequately trained as mandated
under the Standard. NIOSH will
disseminate a one-time customer
satisfaction survey to course directors
and sponsor representatives to evaluate

our service to courses, the effectiveness
of the program changes implemented
since 2005, and the usefulness of
potential Program enhancements.
The annualized figures slightly overestimate the actual burden, due to
rounding of the number of respondents
for even allocation over the three-year
clearance period. The estimated annual
burden to respondents is 159 hours.
There will be no cost to respondents.

ESTIMATED ANNUALIZED BURDEN HOURS
Total burden
(in hours)

Form name

Potential Sponsors ............................

Initial Application ..............................
Annual Report ..................................
Report for course changes ..............
Renewal Application .........................
Refresher Course Application ..........
One-time Customer Satisfaction ......
Survey ..............................................

3
30
24
13
3
32

1
1
1
1
1
1

8
30/60
30/60
6
8
12/60

24
15
12
78
24
6

Total ...........................................

...........................................................

........................

........................

........................

159

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–04047 Filed 3–1–17; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17RT; Docket No. CDC–2017–
0013]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information

SUMMARY:

sradovich on DSK3GMQ082PROD with NOTICES

Average
burden per
response
(in hours)

Number of
responses per
respondent

Number of
respondents

Type of respondents

VerDate Sep<11>2014

16:13 Mar 01, 2017

Jkt 241001

collection project titled ‘‘Factors
Influencing the Transmission of
Influenza.’’ This data collection project
will help examine the amount of
influenza virus in airborne particles
produced by subjects with influenza
and it relationship to biomarkers in the
blood.
DATES: Written comments must be
received on or before May 1, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0013 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of

FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00026

Fmt 4703

Sfmt 4703

the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the

E:\FR\FM\02MRN1.SGM

02MRN1

12361

Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Factors Influencing the Transmission
of Influenza—New—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The National Institute for
Occupational Safety and Health

influenza virus, and the levels of
influenza infection-associated
biomarkers will be measured in blood
samples from these subjects.
Volunteer adult participants will be
recruited by a test coordinator using a
poster and flyers describing the study.
Interested potential participants will be
screened verbally to verify that they
have influenza-like symptoms and that
they do not have any medical
conditions that would preclude their
participation. Qualified participants
who agree to participate in the study
will be asked to read and sign an
informed consent form, and then to
complete a short health questionnaire.
After completing the forms, the
participant’s oral temperature will be
measured and two nasopharyngeal
swabs and five milliliters of blood will
be collected. The participant then will
be asked to cough repeatedly into an
aerosol particle collection system, and
the airborne particles produced by the
participant during coughing will be
collected and tested.
The study will require 40 volunteer
test subjects each year for three years,
for a total of 120 test participants.
NIOSH intends to seek a three-year
OMB approval to conduct this
information collection. There are no
costs to respondents other than their
time.

(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a)(1)
of the 1970 Occupational Safety and
Health Act.
Influenza continues to be a major
public health concern because of the
substantial health burden from seasonal
influenza and the potential for a severe
pandemic. Although influenza is known
to be transmitted by infectious
secretions, these secretions can be
transferred from person to person in
many different ways, and the relative
importance of the different pathways is
not known. The likelihood of the
transmission of influenza virus by small
infectious airborne particles produced
during coughing and breathing is
particularly unclear. The question of
airborne transmission is especially
important in healthcare facilities, where
influenza patients tend to congregate
during influenza season, because it
directly impacts the infection control
and personal protective measures that
should be taken by healthcare workers.
The purpose of this study is to gain
a better understanding of the production
of infectious aerosols by patients with
influenza, and to compare this to the
levels of biomarkers of influenza
infection in the blood of these patients.
To do this, airborne particles produced
by volunteer subjects with influenza
will be collected and tested for

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents

Potential participant
Qualified participant
Qualified participant
Qualified participant

Average
burden per
response
(in hrs.)

Number of
responses per
respondent

Total burden
(in hrs.)

..........................
..........................
..........................
..........................

Initial Verbal Screening ....................
Informed consent form .....................
Health questionnaire ........................
Medical Testing ................................

240
120
120
120

1
1
1
1

3/60
15/60
5/60
40/60

12
30
10
80

Total ...........................................

...........................................................

........................

........................

........................

132

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2017–04045 Filed 3–1–17; 8:45 am]

[30Day–17–16AJE]

BILLING CODE 4163–18–P
sradovich on DSK3GMQ082PROD with NOTICES

Number of
respondents

Form name

Centers for Disease Control and
Prevention

Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for

VerDate Sep<11>2014

16:13 Mar 01, 2017

Jkt 241001

PO 00000

Frm 00027

Fmt 4703

Sfmt 4703

the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of

E:\FR\FM\02MRN1.SGM

02MRN1